Brown Advisory’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-34,525
Closed -$936K 1039
2015
Q4
$936K Hold
34,525
﹤0.01% 577
2015
Q3
$755K Buy
34,525
+1,525
+5% +$38.9K ﹤0.01% 613
2015
Q2
$940K Sell
33,000
-1,670
-5% -$48.7K ﹤0.01% 540
2015
Q1
$948K Buy
34,670
+145
+0.4% +$3.99K ﹤0.01% 561
2014
Q4
$911K Sell
34,525
-550
-2% -$16.1K ﹤0.01% 571
2014
Q3
$1.06M Hold
35,075
﹤0.01% 537
2014
Q2
$1.1M Buy
35,075
+550
+2% +$17.5K ﹤0.01% 537
2014
Q1
$1.12M Buy
+34,525
New +$1.21M ﹤0.01% 520

Other funds holding MR

Brown Advisory's MR Position: Q1 2016 in Review

Brown Advisory sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 34,525 shares — an estimated $936K sold.

Brown Advisory first reported a position in MR in Q1 2014 and held it in 8 quarters. The position peaked at $1.12M in Q1 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Brown Advisory reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Brown Advisory sold 34,525 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $936K.
  • Brown Advisory first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q1 2014 and held it in 8 quarters.
  • Brown Advisory's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1.12M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Brown Advisory's 13F filing for Q1 2016, filed 13 May 2016.